New Study Arm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from New Study Arm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In New Study Arm Today - Breaking & Trending Today

Atossa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update

Published: May 15, 2023

Two Phase 2 trials investigating -endoxifen in neoadjuvant setting initiated and are enrolling patientsFull enrollment of Phase 2 KARISMA mammographic breast density study expected by end of 2023Ended... | May 15, 2023

Source: marketscreener.com

Related Topics:

United StatesKyle GuseEric Van ZantenFoundation For The National Institutes Of HealthCancer Biomarkers ConsortiumAtossa Therapeutics IncAmerican Society Of Clinical OncologyExchange CommissionDrug AdministrationGlobenewswire IncTrademark OfficeTwo PhaseFirst Patient DosedEndoxifen VersusNew Study ArmOngoing PhaseQuantum Leap Healthcare CollaborativeNational InstitutesCancer BiomarkersIntellectual Property ProtectionUnited States PatentClinical OncologyAnnual MeetingChief ExecutiveSelective Estrogen Receptor Modulator